Exact Mass: 645.1928

Exact Mass Matches: 645.1928

Found 24 metabolites which its exact mass value is equals to given mass value 645.1928, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

DPDPE

C30H39N5O7S2 (645.2291)

D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D009294 - Narcotics D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics D018377 - Neurotransmitter Agents > D018847 - Opioid Peptides D018377 - Neurotransmitter Agents > D004745 - Enkephalins DPDPE, an opioid peptide, is a selective δ-opioid receptor?(DOR) agonist?with anticonvulsant effects[1]. DPDPE, an opioid peptide, is a selective δ-opioid receptor?(DOR) agonist?with anticonvulsant effects[1].

Netarsudil Mesylate

C30H35N3O9S2 (645.1815)

C78283 - Agent Affecting Organs of Special Senses > C29705 - Anti-glaucoma Agent

Ustiloxin B

2-amino-5-{[(5Z,8E)-4-[(Z)-(carboxymethyl)-C-hydroxycarbonimidoyl]-3-ethyl-6,9,11,15-tetrahydroxy-3,7-dimethyl-10-(methylamino)-2-oxa-5,8-diazabicyclo[10.3.1]hexadeca-1(16),5,8,12,14-pentaen-13-yl]sulfinyl}-4-hydroxypentanoic acid

C26H39N5O12S (645.2316)

Ustiloxin B is found in cereals and cereal products. Ustiloxin B is isolated from the false smut balls caused by Ustilaginoidea virens on rice. Isolated from the false smut balls caused by Ustilaginoidea virens on rice. Ustiloxin B is found in cereals and cereal products.

(D-Pen2,D-Pen5)-Enkephalin

13-{[2-amino-1-hydroxy-3-(4-hydroxyphenyl)propylidene]amino}-7-benzyl-6,9,12-trihydroxy-3,3,14,14-tetramethyl-1,2-dithia-5,8,11-triazacyclotetradeca-5,8,11-triene-4-carboxylate

C30H39N5O7S2 (645.2291)

ZORUBICIN

N-(1-{4-[(4-amino-5-hydroxy-6-methyloxan-2-yl)oxy]-2,5,12-trihydroxy-7-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-2-yl}ethylidene)benzenecarbohydrazonate

C34H35N3O10 (645.2322)

3-Piperidinecarboxamide, N-((2-chloro-5-(2-methoxyethyl)phenyl)methyl)-N-cyclopropyl-4-(6-(2-(2,6-dichloro-4-methylphenoxy)ethoxy)-3-pyridinyl)-, (3R,4S)-

C33H38Cl3N3O4 (645.1928)

Ustiloxin B

2-amino-5-{4-[(carboxymethyl)carbamoyl]-3-ethyl-11,15-dihydroxy-3,7-dimethyl-10-(methylamino)-6,9-dioxo-2-oxa-5,8-diazabicyclo[10.3.1]hexadeca-1(16),12,14-triene-13-sulfinyl}-4-hydroxypentanoic acid

C26H39N5O12S (645.2316)

A heterodetic cyclic peptide with formula C26H39N5O12S produced by Ustilaginoidea virens fungi. It is an inhibitor of microtubule assembly.

2-(4-N-BOC-AMINOBENZYL)-2,5-DIAZABICYCLO[2.2.1]HEPTANE

C23H28F9N3O8 (645.1733)

chloro[(1,2,3-η)-3-phenyl-2-propenyl][1,3-bis(2,6-di-i-propylphenyl)-4,5-dihydroimidazol-2-ylidene]palladium(ii)

C36H44ClN2Pd (645.2228)

Holmium tris(1,1,1,3,3,3-hexamethyldisilazan-2-ide)

C18H54HoN3Si6 (645.2237)

Grela 1st Generation

C28H44Cl2NO3PRu (645.1479)

3-Oxazolidinecarboxylic acid, 4-[[(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]methyl]-5-hydroxy-2,4-diphenyl-, phenylmethyl ester, (2R,4S)-

C34H29F6NO5 (645.195)

(D-PEN2,PEN5)-ENKEPHALIN

C30H39N5O7S2 (645.2291)

Rubidazon

N-[(E)-1-[(2S,4S)-4-(4-amino-5-hydroxy-6-methyloxan-2-yl)oxy-2,5,12-trihydroxy-7-methoxy-6,11-dioxo-3,4-dihydro-1H-tetracen-2-yl]ethylideneamino]benzamide

C34H35N3O10 (645.2322)

L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01D - Cytotoxic antibiotics and related substances > L01DB - Anthracyclines and related substances C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C259 - Antineoplastic Antibiotic C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor > C1748 - Topoisomerase Inhibitor C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C2842 - DNA Binding Agent D000970 - Antineoplastic Agents

3-[N-[Benzyloxycarbonyl]-phenylalaninyl-amino]-5-phenyl-pentane-1-sulfonic acid 4-nitro-phenyl ester

C34H35N3O8S (645.2145)

4-deoxy-alpha-L-threo-hex-4-enopyranuronosyl-(1->4)-beta-D-glucopyranosyl-(1->4)-alpha-L-rhamnopyranosyl-(1->3)-D-glucopyranose

C24H37O20- (645.1878)

beta-D-Delta(4)-GlcpA-(1->4)-beta-D-Glcp-(1->4)-alpha-L-Rhap-(1->3)-beta-D-Glcp(1-)

C24H37O20- (645.1878)

(3S)-3-{[3,4-difluoro-5-({4-fluoro-6-[(3S)-pyrrolidinium-3-yloxy][biphenyl]-3-yl}carbamoyl)[biphenyl]-2-yl]oxy}pyrrolidinium dichloride

C33H32Cl2F3N3O3 (645.1773)

(2s,4s)-2-amino-5-[(s)-(3s,4s,7r,10s,11r)-4-(carboxymethyl-c-hydroxycarbonimidoyl)-3-ethyl-6,9,11,15-tetrahydroxy-3,7-dimethyl-10-(methylamino)-2-oxa-5,8-diazabicyclo[10.3.1]hexadeca-1(16),5,8,12,14-pentaen-13-ylsulfinyl]-4-hydroxypentanoic acid

(2s,4s)-2-amino-5-[(s)-(3s,4s,7r,10s,11r)-4-(carboxymethyl-c-hydroxycarbonimidoyl)-3-ethyl-6,9,11,15-tetrahydroxy-3,7-dimethyl-10-(methylamino)-2-oxa-5,8-diazabicyclo[10.3.1]hexadeca-1(16),5,8,12,14-pentaen-13-ylsulfinyl]-4-hydroxypentanoic acid

C26H39N5O12S (645.2316)

(2s,4s)-2-amino-5-[(r)-(3r,4s,7s,10s,11r)-4-(carboxymethyl-c-hydroxycarbonimidoyl)-3-ethyl-6,9,11,15-tetrahydroxy-3,7-dimethyl-10-(methylamino)-2-oxa-5,8-diazabicyclo[10.3.1]hexadeca-1(16),5,8,12,14-pentaen-13-ylsulfinyl]-4-hydroxypentanoic acid

(2s,4s)-2-amino-5-[(r)-(3r,4s,7s,10s,11r)-4-(carboxymethyl-c-hydroxycarbonimidoyl)-3-ethyl-6,9,11,15-tetrahydroxy-3,7-dimethyl-10-(methylamino)-2-oxa-5,8-diazabicyclo[10.3.1]hexadeca-1(16),5,8,12,14-pentaen-13-ylsulfinyl]-4-hydroxypentanoic acid

C26H39N5O12S (645.2316)

2-amino-5-[4-(carboxymethyl-c-hydroxycarbonimidoyl)-3-ethyl-6,9,11,15-tetrahydroxy-3,7-dimethyl-10-(methylamino)-2-oxa-5,8-diazabicyclo[10.3.1]hexadeca-1(16),5,8,12,14-pentaen-13-ylsulfinyl]-4-hydroxypentanoic acid

2-amino-5-[4-(carboxymethyl-c-hydroxycarbonimidoyl)-3-ethyl-6,9,11,15-tetrahydroxy-3,7-dimethyl-10-(methylamino)-2-oxa-5,8-diazabicyclo[10.3.1]hexadeca-1(16),5,8,12,14-pentaen-13-ylsulfinyl]-4-hydroxypentanoic acid

C26H39N5O12S (645.2316)